What's up with Nanopore Sequencing? | GenomeWeb

There hasn't been a peep out of Oxford Nanopore Technologies since the company announced in February that its DNA strand sequencing nanopore method is working and that it is developing it commercially. "When will nanopores actually hit the market?" asks Keith Robison at his Omics! Omics! blog.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Science this week: metagenomic-based technique for determining protein structure, and more.

An academic laments the rise of narcissism in the sciences, the Guardian reports.

Outgoing FDA commissioner Robert Califf writes in an editorial that the agency can help boost innovation.

The Trump transition team has asked NIH Director Francis Collins to remain at his post, though it's unclear for how long that will be.